Domicile
Reels
Groupes
Pages
Plus
Groupes Pages Evènements Blogs Financement
Se connecter S’enregistrer
Mode nuit
What Are the Key Challenges Facing the AAV Vector-based Gene Therapy Market?
Despite its promise, the AAV vector-based gene therapy market faces significant challenges that must be addressed for the field to reach its full potential. From pricing to immunogenicity, these barriers affect developers, payers, and patients alike. High treatment costs—often exceeding millions of dollars per patient—raise access and reimbursement concerns. Payers are scrutinizing...
0 Commentaires ·0 Parts ·113 Vue ·0 Aperçu
Connectez-vous pour aimer, partager et commenter!